μ-Conotoxin K IIIA is a cysteine-rich, disulfide-stabilized peptide used to probe voltage-gated sodium channel interactions. Its rigid structure supports highly selective binding studies. Researchers analyze folding pathways, solvent effects, and binding kinetics. Applications include neuropeptide research, channel-mapping studies, and structural biophysics.
CAT No: R2557
CAS No:884469-67-4
Synonyms/Alias:mu-Conotoxin K IIIA;UNII-390H5GUO40;CHEMBL2402969;390H5GUO40;884469-67-4;Ccncsskwcrdhsrcc-NH2 cyclic (1->9),(2->15),(4->16);L-Cysteinamide, L-cysteinyl-L-cysteinyl-L-asparaginyl-L-cysteinyl-L-seryl-L-seryl-L-lysyl-L-tryptophyl-L-cysteinyl-L-arginyl-L-alpha-aspartyl-L-histidyl-L-seryl-L-arginyl-L-cysteinyl-, cyclic (1->9),(2->15),(4->16)-tris(disulfide);mu-Conotoxin KIIIA;BDBM50492340;DA-68915;
2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
3. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More